USD 0.0
(0.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Revenue | 184.39 Thousand | 42.52 Thousand | 2.51 Million | 2.35 Million | 1.96 Million | 107 Thousand |
Cost of Revenue | 96.55 Thousand | 22.07 Thousand | 1.21 Million | 1.82 Million | 101.49 Thousand | 36.03 Thousand |
Gross Profit | 87.84 Thousand | 20.45 Thousand | 1.29 Million | 531.74 Thousand | 1.85 Million | 70.96 Thousand |
Operating Expenses | 3.39 Million | 13.82 Million | 6.61 Million | 10.12 Million | 16.02 Million | 11.52 Million |
Selling, General and Administrative Expenses | 3.39 Million | 13.82 Million | 6.61 Million | 10.12 Million | 16.02 Million | 11.52 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 1.00 | - | - | - | - | - |
Cost and Expenses | 3.49 Million | 13.85 Million | 7.83 Million | 11.94 Million | 16.12 Million | 11.55 Million |
Operating Income | -3.3 Million | -13.8 Million | -5.31 Million | -9.59 Million | -14.16 Million | -11.45 Million |
Interest Expense | 2.36 Million | 11.54 Million | 7.54 Million | 17.01 Million | 23.94 Million | 27.91 Million |
Income Tax Expense | - | -13.8 Thousand | -5317.43 | -9596.12 | -36.00 | -11.45 Million |
Earnings before Tax | -5.48 Million | -25.35 Million | -12.86 Million | -26.61 Million | -38.73 Million | -39.34 Million |
Net Income | -5.48 Million | -25.35 Million | -12.86 Million | -26.61 Million | -38.73 Million | -39.34 Million |
Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.00 |
Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.00 |
Weighted Average Shares Outstanding | 23.83 Billion | 14.19 Billion | 8.23 Billion | 5.15 Billion | 3.56 Billion | 20.97 Billion |
Weighted Average Shares Outstanding (Diluted) | 23.74 Billion | 14.19 Billion | 8.23 Billion | 5.15 Billion | 3.56 Billion | 20.97 Billion |
Gross Margin | 0.48 | 0.48 | 0.52 | 0.23 | 0.95 | 0.66 |
EBIT Margin | 1.04 | -324.76 | -2.11 | -4.08 | -12.53 | -107.03 |
Profit Margin | -29.73 | -596.37 | -5.11 | -11.31 | -19.76 | -367.69 |
EBITDA | 192.49 Thousand | -1.00 | - | - | -629.96 Thousand | 23.39 Thousand |
Earnings Before Tax Margin | -17.93 | -324.76 | -2.11 | -4.08 | -7.22 | -107.03 |
Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
---|---|---|---|---|---|---|
Revenue | - | - | - | 184.39 Thousand | 23.05 Thousand | 59.58 Thousand |
Cost of Revenue | - | - | - | 96.55 Thousand | 46.49 Thousand | 7587.00 |
Gross Profit | - | - | - | 87.84 Thousand | -23.44 Thousand | 51.99 Thousand |
Operating Expenses | - | - | - | 3.39 Million | 565.42 Thousand | 1.25 Million |
Selling, General and Administrative Expenses | - | - | - | - | 565.42 Thousand | 1.25 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | - | - | - | 3.49 Million | 611.92 Thousand | 1.26 Million |
Operating Income | - | - | - | -3.3 Million | -588.87 Thousand | -1.2 Million |
Interest Expense | - | - | - | 2.36 Million | 363.63 Thousand | 380.84 Thousand |
Income Tax Expense | - | - | - | -3306.42 | -588.87 | -1205.80 |
Earnings before Tax | - | - | - | -5.48 Million | -952.51 Thousand | -1.58 Million |
Net Income | - | - | - | -5.48 Million | -952.51 Thousand | -1.58 Million |
Earnings Per Share Basic | - | - | - | - | - | -0.00 |
Earnings Per Share Diluted | - | - | - | - | - | -0.00 |
Weighted Average Shares Outstanding | - | - | - | 23.74 Billion | 23.74 Billion | 17.65 Billion |
Weighted Average Shares Outstanding (Diluted) | - | - | - | 23.74 Billion | 23.74 Billion | 17.65 Billion |
Gross Margin | - | - | - | 0.48 | -1.02 | 0.87 |
EBIT Margin | - | - | - | - | -25.54 | -20.24 |
Profit Margin | - | - | - | -29.73 | -41.32 | -26.63 |
EBITDA | - | - | - | - | -588.87 Thousand | -1.2 Million |
Earnings Before Tax Margin | - | - | - | -17.93 | -25.54 | -20.24 |
603867
2185
DKS
0P49
SMSPHARMA
STLJF